Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Aspirin metabolism may hold key to preventing preeclampsia

NCT ID NCT06802861

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 24 times

Summary

This study looks at how the body processes aspirin in pregnant women who are at risk for preeclampsia, a serious condition involving high blood pressure. Researchers will measure aspirin byproducts and markers of metabolic health in 50 participants. The goal is to better understand why some women benefit more from aspirin than others, which could lead to more personalized prevention.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Tennessee Medical Center

    RECRUITING

    Knoxville, Tennessee, 37920, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.